HAVCR2 and neoplasm: The expression of Tim-3 on tumor cells has been detected in various cancers, including melanoma [47], non-small-cell lung cancers [48], osteosarcoma [49], malignant pleural mesothelioma [50], clear-cell renal cell carcinoma [51], cervical cancer [52], and bladder urothelial carcinoma [53].